Product image of Nitrofurantoin Generics [uk] Limited (Nitrofurantoin) supplied by GNH India

Nitrofurantoin Generics [uk] Limited

Active Ingredient:
Nitrofurantoin
Origin:
EU

Nitrofurantoin Generics [uk] Limited (Nitrofurantoin)

Nitrofurantoin, the active ingredient in Nitrofurantoin Generics, is a nitrofuran antibiotic presented as an oral tablet for oral use. It treats uncomplicated urinary tract infections, particularly cystitis, in adult patients. It is indicated for the treatment of uncomplicated urinary tract infections caused by susceptible bacteria, and is commonly prescribed in primary care settings.

GNH India supplies Nitrofurantoin Generics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourced from EU manufacturers and meeting European quality standards.

Manufacturer / TM Owner

Generics [uk] Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nitrofurantoin is a nitrofuran antibiotic used to treat infections of the urinary tract.

  • Uncomplicated urinary tract infection (cystitis): eliminates susceptible bacteria, relieving dysuria, frequency and urgency.
  • Prophylaxis of recurrent urinary tract infection: reduces recurrence rates in patients with a history of repeated infections.
  • Acute lower urinary tract infection: provides rapid bactericidal activity to resolve symptoms.

How It Works

  • Nitrofurantoin is reduced by bacterial nitroreductases to reactive nitro‑furanyl intermediates that bind to bacterial DNA and other macromolecules. This damage interferes with nucleic acid synthesis and essential enzymatic processes, leading to bacterial cell death. Its selective accumulation in the renal tubules ensures effective antimicrobial activity at the site of infection.

Side Effects

Nitrofurantoin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Nausea: mild stomach upset often occurring early in therapy.
  • Diarrhea: loose stools that may be self‑limiting.
  • Rash: skin redness or itching.

Serious or Rare Side Effects

  • Pulmonary toxicity: interstitial pneumonitis or fibrosis requiring discontinuation.
  • Hepatic injury: elevated liver enzymes or hepatitis.
  • Peripheral neuropathy: tingling or numbness, especially with prolonged use.

Precautions & Warnings

When prescribing nitrofurantoin, several safety considerations should be reviewed to minimize risk.

  • Renal function assessment: evaluate creatinine clearance before initiating therapy.
  • Pregnancy: avoid use in the first trimester and near term unless benefits outweigh risks.
  • G6PD deficiency: contraindicated due to risk of hemolysis.
  • Elderly patients: monitor for signs of pulmonary toxicity and adjust dose if needed.
  • Drug interactions: review concomitant medications for potential absorption or metabolic effects.
  • Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Avoid Interactions

Nitrofurantoin can interact with other medicines, affecting its absorption or increasing toxicity.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: markedly reduce nitrofurantoin absorption.
  • Probenecid: increases nitrofurantoin serum concentrations, raising toxicity risk.
  • Cimetidine: may elevate nitrofurantoin levels, leading to adverse effects.

Moderate Interactions (Monitor Closely)

  • Warfarin: nitrofurantoin may potentiate anticoagulant effect; monitor INR.
  • Phenytoin: may decrease nitrofurantoin efficacy; assess clinical response.
  • Fluoroquinolones: combined use may increase risk of tendonitis; observe for musculoskeletal symptoms.

Frequently Asked Questions

Nitrofurantoin Generics is used to treat uncomplicated urinary tract infections, especially cystitis, caused by susceptible bacteria. It is commonly prescribed in outpatient and primary‑care settings to relieve symptoms such as dysuria, frequency and urgency.

Nitrofurantoin is activated by bacterial nitroreductases, producing reactive intermediates that bind to DNA and other macromolecules. This interferes with nucleic acid synthesis and essential enzymes, resulting in bacterial cell death and clearance of the infection.

The dose of nitrofurantoin is determined by the prescribing clinician based on the severity of infection, renal function and patient‑specific factors. The prescriber will select the appropriate strength, frequency and duration according to current clinical guidelines.

Safety data for nitrofurantoin in pregnancy are limited; it is generally avoided in the first trimester and near term unless the benefits outweigh potential risks. Limited information is available for breastfeeding, so clinicians should assess risk versus benefit before use.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Nitrofurantoin offers high urinary concentrations with limited systemic exposure, making it effective for lower‑tract infections. Compared with broad‑spectrum agents such as trimethoprim‑sulfamethoxazole, it has a lower risk of promoting resistance but is unsuitable for patients with impaired renal function.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Nitrofurantoin is taken orally, usually with food or milk to improve tolerability and absorption. The tablet should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include pulmonary toxicity such as interstitial pneumonitis or fibrosis, hepatic injury, and peripheral neuropathy, especially with prolonged therapy. Patients should be monitored for respiratory symptoms, liver function changes and neurological signs, and the drug should be stopped if severe reactions occur.

Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min), known hypersensitivity to the drug, and those with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency due to the risk of hemolysis. Caution is also advised in pregnant women near term.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.